Dog Antibiotics May Reach the Infection Site Unevenly

An exploratory study in 9 healthy Beagles found that antibiotic drug levels at a potential infection site may differ from what is measured in the blood, suggesting blood tests alone may not capture the full picture of antibiotic exposure where it matters most.

Journal: Antibiotics
Sample Size: 9 healthy Beagles
Study Type: Exploratory pharmacokinetic and PK/PD modeling study
Published: 2026-07-23
Species:

Key Findings

  • Investigators modeled enrofloxacin and ciprofloxacin exposure in plasma and interstitial fluid.
  • Drug concentrations at a potential infection site may differ from plasma measurements.

When your dog is prescribed antibiotics, you probably trust that the medication is fighting the infection. But do antibiotics actually reach the infected tissue? A small exploratory study published in Antibiotics suggests the answer may be more complicated than many pet owners realize. The drug levels measured in a dog’s blood may not fully reflect what is happening at the actual infection site.

This research used 9 healthy Beagles to study two common veterinary antibiotics — enrofloxacin and its active byproduct, ciprofloxacin. The finding that drug concentrations can differ between the blood and the infection site is an early but important step toward better antibiotic dosing for dogs.

Why Measuring Blood Levels May Not Be Enough

When a vet prescribes an antibiotic, the goal is simple: get enough of the drug to the place where bacteria are living and multiplying. For decades, measuring drug levels in blood (called plasma) has been the standard way to estimate how much drug a patient is getting.

The problem is that blood is not always where the infection is. Many dog infections happen in tissues — skin, joints, the space between cells. Drug levels in those tissues may be higher or lower than blood levels. If there is a significant gap, a dose that looks adequate on a blood test might fall short where it actually needs to work.

This gap between blood levels and tissue levels is not a new concept in human medicine. But the data for dogs has been limited, which is what this study set out to begin addressing.

About the Study: 9 Beagles, Two Antibiotics

Researchers in Hungary enrolled 9 healthy adult Beagles in an exploratory pharmacokinetic study. Pharmacokinetics is the science of how the body handles a drug — how it is absorbed, distributed, and eliminated over time. Think of it as tracking a drug’s journey through the body.

The two drugs studied were:

  • Enrofloxacin — a fluoroquinolone antibiotic widely used in veterinary medicine for bacterial infections in dogs.
  • Ciprofloxacin — enrofloxacin’s active metabolite, meaning the body converts enrofloxacin into ciprofloxacin as it processes the drug. Both forms can fight bacteria.

The researchers measured drug concentrations in two places:

  • Plasma — the liquid part of blood, reflecting what circulates throughout the body.
  • Interstitial fluid — the fluid that fills the spaces between cells in tissues. This is often closer to where a real infection would be.

They then used a mathematical modeling approach called nonlinear mixed-effects modeling to analyze how the drugs moved between these compartments. The team also ran what is called a PK/PD target attainment analysis — a way of estimating whether the drug exposure was likely to be sufficient to fight a bacterial infection at the tissue level.

What the Study Found

The study found that drug concentrations at a potential infection site — the interstitial fluid — may differ from what is measured in plasma. In other words, the blood level and the tissue level told different stories.

This is a meaningful distinction. For antibiotics like enrofloxacin and ciprofloxacin, effectiveness depends on reaching an adequate drug concentration relative to the target bacteria. If the concentration at the infection site is lower than expected based on blood measurements, the treatment may be less effective than it appears. If it is higher, the opposite may be true.

The researchers used mathematical modeling to characterize this difference. The results are exploratory — a first look at a pattern worth investigating further, not a definitive answer.

What This Means for Your Dog’s Antibiotic Treatment

If your dog is being treated for a bacterial infection, this study is not a reason to question your vet’s prescription or adjust the dose on your own. The study authors were clear: this was a small exploratory study in healthy dogs, and its findings should not be used to self-adjust veterinary prescriptions.

What this research does highlight is that the science of antibiotic dosing in dogs is still evolving. Vets rely on dosing guidelines built from the best available evidence. Studies like this one contribute to that evidence base over time, potentially improving how future dosing recommendations are developed.

If your dog is on antibiotics and not improving as expected, the right step is to call your vet. There may be many other reasons a treatment is not working — the bacteria might be resistant, the infection type might require a different drug, or other factors may be at play. Your vet is the right person to figure out what is happening and adjust the plan.

A Small Study With Honest Limits

The researchers were upfront about the study’s boundaries. Nine Beagles is a small number, and all of them were healthy. Real-world infections happen in sick dogs with varying body conditions, other health issues, and individual differences that can affect how drugs move through the body.

The findings from healthy dogs in a controlled setting may not translate directly to a dog fighting an active infection. Future research with larger groups and dogs that have actual infections will be needed to confirm and build on these early results.

This kind of early-stage science is how better treatments eventually get developed. It is not the final word — it is the beginning of a longer conversation in veterinary medicine.

What Owners Should Take From This Study

A small exploratory study in 9 Beagles found that antibiotic drug levels at potential infection sites may differ from blood measurements. This is early research, and it should not change how you follow your vet’s instructions. But it is a useful reminder that antibiotic dosing in dogs is a complex science, and researchers are actively working to improve it.

If your dog is on antibiotics for a bacterial infection, complete the full course as directed, watch for signs of improvement, and contact your vet if something does not seem right. Do not adjust doses based on this or any other early study.


This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.

Reference

Patrik Mag, Zoltán Somogyi, Andrea Kertenics, et al. "Exploratory Pharmacokinetic Characterization of Enrofloxacin and Ciprofloxacin in Plasma and Interstitial Fluid of Dogs: Nonlinear Mixed-Effects Modeling and PK/PD Target Attainment Analysis". Antibiotics. 2026-07-23. DOI: https://doi.org/10.3390/antibiotics15080716